Table 1.

Clinical Data of Sampled Patients

Patient ID	Sex	Risk behavior	Year of diagnosisa	CD4 (cells/ml)	Viral load (copies/ml)	Antiretroviral treatment
0008SP	Female	HT	1996	595	450	NRTI+NRTI
0063SP	Male	HT, IDU, BT	1985	10	45,600	NRTI+NRTI+PI
0264RI	Male	MSM, IDU	1995	632	22,000	None
0341RI	Female	HT, BT	1995	554	54,500	NRTI+NRTI
0614SV	Male	HT	1998	499	<50	NRTI+NRTI+PI
0632SV	Male	HT	2003	169	150,347	NRTI+NRTI+PI
0647SV	Male	HT	1995	442	12,284	None
0679SV	Male	HT	1995	202	5,665	NRTI+NRTI+PI
0736SV	Male	MSM, IDU	1992	693	890	NRTI+NRTI
0744SV	Female	HT, BT	2003	na	22,395	NRTI+NRTI

^aPatient reported date of first positive HIV test.

IDU, injecting drug user; MSM, men who have sex with men; HT, heterosexual; BT, blood transfusion; na, not available; NRTI, nucleoside reverse transcriptase inhibitor; PI, protease inhibitor.